EGRX
Eagle Pharmaceuticals Inc
Price:  
2.14 
USD
Volume:  
4,664,101.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX EV/EBITDA

6096.1%
Upside

As of 2025-02-18, the EV/EBITDA ratio of Eagle Pharmaceuticals Inc (EGRX) is 0.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EGRX's latest enterprise value is 69.99 mil USD. EGRX's TTM EBITDA according to its financial statements is 87.82 mil USD. Dividing these 2 quantities gives us the above EGRX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.0x - 14.9x 11.8x
Forward P/E multiples 12.7x - 23.7x 18.2x
Fair Price 86.37 - 176.32 132.60
Upside 3936.2% - 8139.4% 6096.1%
2.14 USD
Stock Price
132.60 USD
Fair Price

EGRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-14 0.72
2025-02-13 0.72
2025-02-12 0.72
2025-02-11 0.72
2025-02-10 0.72
2025-02-07 0.70
2025-02-06 0.69
2025-02-05 0.69
2025-02-04 0.69
2025-02-03 0.69
2025-01-31 0.69
2025-01-30 0.69
2025-01-29 0.69
2025-01-28 0.69
2025-01-27 0.70
2025-01-24 0.70
2025-01-23 0.69
2025-01-22 0.68
2025-01-21 0.68
2025-01-17 0.68
2025-01-16 0.68
2025-01-15 0.67
2025-01-13 0.68
2025-01-10 0.68
2025-01-08 0.67
2025-01-07 0.67
2025-01-06 0.67
2025-01-03 0.66
2025-01-02 0.66
2024-12-31 0.66
2024-12-30 0.66
2024-12-27 0.66
2024-12-26 0.67
2024-12-24 0.67
2024-12-23 0.67
2024-12-20 0.67
2024-12-19 0.67
2024-12-18 0.68
2024-12-17 0.68
2024-12-16 0.68
2024-12-13 0.68
2024-12-12 0.67
2024-12-11 0.68
2024-12-10 0.69
2024-12-09 0.69
2024-12-06 0.69
2024-12-05 0.70
2024-12-04 0.70
2024-12-03 0.69
2024-12-02 0.68